Mitochondrial research peptides in Canada
MOTS-C, SS-31 and NAD+, studied for cellular energy and mitochondrial function. The NAD+ literature includes several controlled human trials; the peptide work is largely preclinical.
SLU-PP-332
Synthetic pan-ERR (ERRα/β/γ) agonist, small molecule
from $71.00HPLC · CoA
Add 2 more to save 4%
SS-31
Mitochondria-targeting tetrapeptide (cardiolipin binder)
from $70.50HPLC · CoA
Add 2 more to save 4%
How these compare
| Compound | Class | Sizes | From |
|---|---|---|---|
| SLU-PP-332 | Synthetic pan-ERR (ERRα/β/γ) agonist, small molecule | 5 mg | $71.00 |
| MOTS-C | Mitochondrial-derived peptide | 10 mg · 40 mg | $42.00 |
| NAD+ | Redox coenzyme (dinucleotide), not a peptide | 500 mg · 1000 mg | $46.50 |
| SS-31 | Mitochondria-targeting tetrapeptide (cardiolipin binder) | 10 mg | $70.50 |